In an article in the March 2008 issue (1), there are several errors that must be noted.

  1. The country for all the authors should be “Taiwan, Republic of China.”

  2. A second corresponding author should be note for requests for reprints:

    Chungming Chang, Division of Molecular and Genomic Medicine, National Health Research Institutes, 35, Keyan Road, Zhunan Town, Miaoli County 350, Taiwan. Phone: 886-37-246-166 ext. 31720/Fax: 886-37-586-463, E-mail:

  3. The legend for Figure 4 should read, “Representatives of grade 3 hepatocellular carcinoma (poor differentiation; D–F). Middle (B, E, and H) and right (C, F, I) immunohistochemistry of UK114 in the tumor liver tissue and adjacent normal liver tissue, respectively.”

  4. The third paragraph (line 7) of the “Discussion” section on page 541 should read “UK114 on the invasion activity of human HepG2 cells”.

In Table 1 the following changes should be noted.

The labels must be added for Class I, Class II and Class III in the UK114 staining score column.

The P-values in the Grade 3 column are <0.001 and >0.05, respectively.

The P-values in the Grade 4 column are <0.001.

Chong C-L, et al. Decreased expression of UK114 is related to the differentiation status of human hepatocellular carcinoma.
Cancer Epidemiol Biomarkers Prev